Supports research to develop and validate novel genetic and non-genetic tools that enable detailed analysis of complex brain circuits and cellular interactions. Emphasizes tools with cell-type and circuit-level specificity, applicable across multiple species, and that break through current technical limitations. Validation of tool utility is essential. Clinical trials are not allowed.
Eligible applicants include nonprofits, tribal organizations, private and public institutions of higher education, for-profit organizations, small businesses, and various government entities within the United States. Specific eligibility details are provided in the announcement.